Abstract:Polycystic ovary syndrome (PCOS) affects 5% to 10% of women of reproductive age worldwide and is one of the most common endocrine disorders with clinical manifestations of oligo-ovulation, anovulation, and polycystic ovarian changes. According to some studies, PCOS is an inflammatory disease that exerts effects on ovulation and the ovarian/follicular microenvironment. [ 1–4 ] Patients with PCOS have considerably higher serum levels of IL-6, natural killer cells, leukocytes, and the levels of IL-1β and IL-18 in follicular fluid than healthy individuals. [ 4–8 ] The inflammatory response of PCOS also exerts significant impact on the proliferation and apoptosis of granulosa cells (GCs). [ 9 ] However, few studies have investigated the mechanisms of inflammation in PCOS and there is a clear need to further investigate the specific characteristics of inflammation in PCOS. Recent research discovered that excessive amounts of copper can stimulate protein acylation in the tricarboxylic acid (TCA) cycle, and that this represents a novel trigger of cell death. [ 10 ] The TCA cycle is a biochemical pathway that is commonly found in aerobic organisms which is the center of lipid, amino acid, and carbohydrate metabolism and plays an important role in regulating metabolism, cell function, and cell fate. [ 11 ] Patients with PCOS exhibit problems with the TCA cycle, glucose, and lipid metabolism. [ 12 ] Furthermore, the TCA cycle plays an important role in the proliferation and death of GCs and immune cells, as well as immunological function. Disruption of the TCA cycle results in abnormal amino acid and lipid metabolism, which can lead to accumulation of citric and succinic acids in macrophages, which can promote immune function. [ 13 ] Furthermore, lipid oxidation within the TCA cycle is critical for the activity and lifespan of CD8 + T and Treg cells. [ 14 ] Previous research found that PCOS patients with a high incidence of cyst formation possessed GCs containing fewer TCA metabolites in their mitochondria, thus resulting in reduced levels of inflammation, thereby increasing cyst rates. [ 15 ] Copper ions are intimately associated with the development of PCOS patients who exhibit increased levels of copper in the serum and follicular fluid. [ 16–18 ] Collectively, these studies reported evidence that copper ions may have an effect on the development of PCOS and immune infiltration.

Identification of necroptosis-related gene expression and the immune response in polycystic ovary syndrome

A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs

Aberrant Expression and DNA Methylation of Lipid Metabolism Genes in PCOS: a New Insight into Its Pathogenesis.

Identification of CCR7 As a Potential Biomarker in Polycystic Ovary Syndrome Through Transcriptome Sequencing and Integrated Bioinformatics

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer

Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis

Elucidating the Role of Autophagy-related Genes in Polycystic Ovary Syndrome: Implications for Diagnostic Models and Immune Response Regulation

Exploration of the Relationship between Polycystic Ovary Syndrome and Recurrent Pregnancy Loss Based on Bioinformatics

Bioinformatics analysis of the role of RNA modification regulators in polycystic ovary syndrome

Identification of the Shared Gene Signatures and Pathways Between Polycystic Ovary Syndrome and Endometrial Cancer: an Omics Data Based Combined Approach.

Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer

Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation

Unveiling Circular RNA-Mediated Regulatory Mechanisms in Necroptosis in Premature Ovarian Failure

Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway

Identification and validation of senescence-related genes in polycystic ovary syndrome

Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome

Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer through Bioinformatics

Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome

Research Advances in the Role of Inflammatory Factors in Polycystic Ovary Syndrome

Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome

Identification of shared gene signatures and biological mechanisms between preeclampsia and polycystic ovary syndrome